| 产品详情 |
| Edit |   |
|---|
| Product Name | JNJ-1661010 |
|---|
| Description | Purity >98%. Fatty acid amide hydrolase (FAAH) degrades N-acyl ethanolamines, including the endocannabinoid arachidonoyl ethanolamide (AEA). JNJ-1661010 is a selective inhibitor of FAAH (IC50 s = 34 and 33 nM in rat and human, respectively) that is able to cross the blood-brain barrier. At 20 mg/kg, JNJ-1661010 has been shown to elevate levels of AEA in rat brain. This compound has been used to examine the contribution of endocannabinoid signaling in experimental fibrosis. |
|---|
| Size | n/a |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | N-phenyl-4-(3-phenyl-1,2,4-thiadiazol-5-yl)-1-piperazinecarboxamide |
|---|
| Gene, Accession, CAS # | CAS: 681136-29-8 |
|---|
| Catalog # | LS-H8294 |
|---|
| Price | |
|---|
| Order / More Info | JNJ-1661010 from LIFESPAN BIOSCIENCES INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|